Abstract
Thirty-nine patients with mild to moderate essential hypertension participated in a parallel, single-blind study comparing 6 weeks' treatment of nicardipine hydrochloride (90 mg/day) with nifedipine (40 mg/day). Nicardipine-treated patients commenced therapy with a significantly higher mean supine diastolic blood pressure than the nifedipine-treated patients. There was a statistically significant fall in blood pressure (systolic and diastolic) on both treatments at the 3 and 6 week follow-up visits. On adjusting the results for the baseline inequality, no statistically significant differences were found between treatment groups. Seven patients withdrew from nifedipine therapy and six patients withdrew from nicardipine therapy due to adverse events. The results show that nicardipine hydrochloride at 90 mg/day is an effective anti-hypertensive agent. The incidence and nature of adverse events were similar on the two treatments.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brennan F., Flanagan M., Blake S., Cannon P. Nifedipine in the treatment of hypertension. Eur J Clin Pharmacol. 1983;25(6):713–715. doi: 10.1007/BF00542507. [DOI] [PubMed] [Google Scholar]
- Gill J. S., Zezulka A. V., Beevers D. G., Davies P. Relation between initial blood pressure and its fall with treatment. Lancet. 1985 Mar 9;1(8428):567–569. doi: 10.1016/s0140-6736(85)91219-x. [DOI] [PubMed] [Google Scholar]
- Hallin L., Andrén L., Hansson L. Controlled trial of nifedipine and bendroflumethiazide in hypertension. J Cardiovasc Pharmacol. 1983 Nov-Dec;5(6):1083–1085. doi: 10.1097/00005344-198311000-00025. [DOI] [PubMed] [Google Scholar]
- Hornung R. S., Gould B. A., Jones R. I., Sonecha T., Raftery E. B. Nifedipine tablets for hypertension: a study using continuous ambulatory intra-arterial recording. Postgrad Med J. 1983;59 (Suppl 2):95–97. [PubMed] [Google Scholar]
- Hulthén U. L., Bolli P., Bühler F. R. Calcium influx blockers in the treatment of essential hypertension. Acta Med Scand Suppl. 1984;681:101–108. doi: 10.1111/j.0954-6820.1984.tb08683.x. [DOI] [PubMed] [Google Scholar]
- Littler W. A., Stallard T. J., Watson R. D., McLeay R. A. The effect of nifedipine on arterial pressure and reflex cardiac control. Postgrad Med J. 1983;59 (Suppl 2):109–113. [PubMed] [Google Scholar]
- MacGregor G. A., Markandu N. D., Rotellar C., Smith S. J., Sagnella G. A. The acute response to nifedipine is related to pre-treatment blood pressure. Postgrad Med J. 1983;59 (Suppl 2):91–94. [PubMed] [Google Scholar]
- Midtbø K., Hals O., van der Meer J. Verapamil compared with nifedipine in the treatment of essential hypertension. J Cardiovasc Pharmacol. 1982;4 (Suppl 3):S363–S368. [PubMed] [Google Scholar]
- Murphy M. B., Scriven A. J., Dollery C. T. Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) 1983 Jul 23;287(6387):257–259. doi: 10.1136/bmj.287.6387.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spivack C., Ocken S., Frishman W. H. Calcium antagonists. Clinical use in the treatment of systemic hypertension. Drugs. 1983 Feb;25(2):154–177. doi: 10.2165/00003495-198325020-00004. [DOI] [PubMed] [Google Scholar]
- Taylor S. H., Silke B., Ahuja R. C., Okoli R. Influence of nicardipine on the blood pressure at rest and on the pressor responses to cold, isometric exertion, and dynamic exercise in hypertensive patients. J Cardiovasc Pharmacol. 1982 Sep-Oct;4(5):803–807. doi: 10.1097/00005344-198209000-00016. [DOI] [PubMed] [Google Scholar]
- Young M. A., Watson R. D., Littler W. A. Baroreflex setting and sensitivity after acute and chronic nicardipine therapy. Clin Sci (Lond) 1984 Feb;66(2):233–235. doi: 10.1042/cs0660233. [DOI] [PubMed] [Google Scholar]